COLAGROSSI, LUNA
 Distribuzione geografica
Continente #
NA - Nord America 2.509
AS - Asia 883
EU - Europa 692
SA - Sud America 190
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 31
OC - Oceania 4
Totale 4.434
Nazione #
US - Stati Uniti d'America 2.459
SG - Singapore 346
IT - Italia 238
BR - Brasile 152
CN - Cina 131
RU - Federazione Russa 110
BD - Bangladesh 107
HK - Hong Kong 83
VN - Vietnam 75
DE - Germania 59
IE - Irlanda 57
KR - Corea 48
SE - Svezia 43
FI - Finlandia 41
FR - Francia 36
JP - Giappone 33
GB - Regno Unito 32
CA - Canada 24
MX - Messico 16
IN - India 15
NL - Olanda 15
AR - Argentina 14
ZA - Sudafrica 14
PL - Polonia 13
CZ - Repubblica Ceca 10
ID - Indonesia 10
TR - Turchia 10
UA - Ucraina 10
AT - Austria 8
ES - Italia 8
PY - Paraguay 7
CO - Colombia 6
AU - Australia 4
KE - Kenya 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
IQ - Iraq 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
TZ - Tanzania 3
CH - Svizzera 2
GR - Grecia 2
MA - Marocco 2
NI - Nicaragua 2
RS - Serbia 2
SA - Arabia Saudita 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
NG - Nigeria 1
PR - Porto Rico 1
RO - Romania 1
TD - Ciad 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.310
Città #
Wilmington 478
Houston 346
Singapore 187
San Jose 141
Woodbridge 132
Ashburn 119
Fairfield 98
Chandler 92
Council Bluffs 89
Hong Kong 81
Beijing 74
New York 67
Rome 62
The Dalles 49
Dallas 48
Dublin 44
Los Angeles 43
Santa Clara 38
Seattle 37
Tokyo 32
Cambridge 29
Munich 28
Milan 27
Helsinki 26
Ho Chi Minh City 26
Ann Arbor 25
Medford 24
Dearborn 18
Moscow 18
Buffalo 17
Denver 16
Hanoi 15
São Paulo 13
London 12
Johannesburg 11
Lappeenranta 11
Lauterbourg 11
Lawrence 11
Engelhard 10
Frankfurt am Main 10
Nuremberg 10
Warsaw 10
Chicago 9
Atlanta 8
Menlo Park 8
Orem 8
San Diego 8
Boston 7
Montreal 7
North Bergen 7
Stockholm 7
Toronto 7
Boardman 6
Creede 6
Jakarta 6
Olomouc 6
Phoenix 6
Poplar 6
Querétaro 6
Redondo Beach 6
Rio de Janeiro 6
St. George 6
Cedarhurst 5
Chennai 5
Colorado Springs 5
Fortaleza 5
Hải Dương 5
Modena 5
Naples 5
Nepi 5
San Francisco 5
Albano Laziale 4
Bologna 4
Brno 4
Manchester 4
Mexico City 4
Amsterdam 3
Ankara 3
Asunción 3
Biên Hòa 3
Brooklyn 3
Charlotte 3
Dar es Salaam 3
Florence 3
Guangzhou 3
Guarulhos 3
Istanbul 3
Jacksonville 3
Las Vegas 3
Manaus 3
Miami 3
Minneapolis 3
Monte Vista 3
Nairobi 3
Nova Iguaçu 3
Palazzolo sull'Oglio 3
Piscataway 3
Salvador 3
Shanghai 3
Antakya 2
Totale 2.907
Nome #
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 457
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 386
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 337
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 269
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe 263
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection 261
CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases 141
Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups – The CONVERS project, report from a pediatric tertiary hospital 132
Managing low-level HIV viraemia in antiretroviral therapy: a systematic review and meta-analysis 131
Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B 130
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed? 123
SARS-CoV-2 genomic surveillance and reliability of PCR single point mutation assay (SNPsig® SARS-CoV-2 EscapePLEX CE) for the rapid detection of variants of concern in Cameroon 120
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 110
Management of low-level HIV viremia during antiretroviral therapy: Delphi consensus statement and appraisal of the evidence 110
Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies 108
Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome 102
Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment 101
Highly specific memory b cells generation after the 2nd dose of bnt162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal iga 99
A new epidemic wave of Bordetella pertussis in paediatric population: impact and role of co-infections in pertussis disease 98
Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens 98
Parvovirus B19 Rebound 97
Presence and Significance of Multiple Respiratory Viral Infections in Children Admitted to a Tertiary Pediatric Hospital in Italy 95
Safety of Nirmatrelvir-Ritonavir Administration in Children With Immunodeficiency and/or Comorbidities With SARS-CoV-2 Infection A Retrospective Clinical Report 94
An increase in the levels of middle surface antigen characterizes patients developing HBV-driven liver cancer despite prolonged virological suppression 91
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity 90
Influenza viruses circulation in a tertiary care children hospital in Rome: a comparison between 2022 and the previous 5 years 75
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units 73
Whooping Cough Cases Increase in Central Italy after COVID-19 Pandemic 64
Diagnostic Concordance of Two- and Three-Gene SARS-CoV-2 Molecular Assays in Cameroon: Implications for Efficient Pandemic Response in Low- and Middle-Income Countries 58
Humoral and cellular immunogenicity and safety up to 4 months after vaccination with BNT162B2 mRNA COVID-19 vaccine in heart and lung transplanted young adults 57
Viral dynamics and factors associated with duration of COVID-19 positivity: evidence from the first-three epidemiological waves in Cameroon 29
Viral Burden of Respiratory Syncytial Virus and Viral Coinfections as Factors Regulating Paediatric Disease Severity 18
Whole-Genome Sequencing of Adenovirus Genotypes and Clinical Implications in Pediatric Patients 17
Totale 4.434
Categoria #
all - tutte 16.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 0 4 20 3 7 1 54 11 6 32
2022/2023300 18 26 18 20 39 45 40 24 27 9 28 6
2023/2024141 10 21 12 4 19 28 13 4 2 11 1 16
2024/2025718 14 105 63 36 21 41 64 60 79 85 71 79
2025/20261.646 136 89 193 147 144 70 167 177 133 154 162 74
2026/2027219 102 75 42 0 0 0 0 0 0 0 0 0
Totale 4.434